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Although a number of genes expressed in most tissues, including the liver, exhibit circadian 
regulation, gene expression profiles are usually examined only at one scheduled time each 
day.  In this study, we investigated the effects of obese diabetes on the hepatic mRNA levels 
of various genes at 6-h intervals over a single 24-h period.  Microarray analysis revealed 
that many genes are expressed rhythmically, not only in control KK mice but also in obese 
diabetic KK-Ay mice.  Real-time quantitative PCR verified that 19 of 23 putative 
circadianly expressed genes showed significant 24-h rhythmicity in both strains.  However, 
obese diabetes attenuated these expression rhythms in 10 of 19 genes.  More importantly, 
the effects of obese diabetes were observed throughout the day in only two genes.  These 
results suggest that observation time influences the results of gene expression analyses of 
genes expressed circadianly. 
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Many physiological and behavioral processes exhibit circadian, 24-h rhythmicity.  
Recent studies have revealed that these endogenous rhythms are generated at the cellular 
level by circadian core oscillators, which are composed of transcriptional/translational 
feedback loops involving a set of clock genes [1,2].  In mammals, rhythmic transcriptional 
enhancement by two basic helix-loop-helix Per-Arnt-Sim domain-containing transcription 
factors, CLOCK and brain and muscle Arnt-like protein 1 (BMAL1), provides the basic 
drive for the intracellular clock system; the CLOCK-BMAL1 heterodimer activates the 
transcription of various clock-controlled genes [3,4].  Given that some clock-controlled 
genes, including the albumin D-site binding protein (Dbp), also serve as transcription 
factors, the expression of numerous genes may be tied to the molecular clock [1,2].  In 
parallel, the CLOCK-BMAL1 heterodimer activates the transcription of the Period (PER) 
and Cryptochrome (CRY) genes [5-7].  When the PER and CRY proteins reach a critical 
concentration, they attenuate CLOCK-BMAL1 transactivation, thereby generating a 
circadian oscillation in their own transcription [4,5]. 
The molecular clock system resides not only in the hypothalamic suprachiasmatic 
nucleus, which is recognized as the mammalian central clock, but also in various peripheral 
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tissues [8-10].  The suprachiasmatic nucleus is not essential for driving peripheral 
oscillations but acts as to synchronize peripheral oscillators [10].  Therefore, the local 
molecular clock may directly control the physiological rhythmicity in peripheral tissues. 
Recent studies have suggested that malfunction of the molecular clock system is 
involved in the development of metabolic syndrome, which is a constellation of metabolic 
abnormalities including obesity, dyslipidemia, hypertension, and insulin resistance/type 2 
diabetes [11].  In mice, inactivation of BMAL1 suppresses the diurnal variation in plasma 
glucose and triglyceride concentrations and can lead to insulin resistance [12].  Moreover, 
homozygous Clock mutant mice have an attenuated diurnal feeding rhythm, are 
hyperphagic and obese, and develop hyperglycemia, hyperlipidemia, and hepatic steatosis 
[13].  Furthermore, we have shown that the rhythmic expression of clock genes is 
attenuated in the liver and visceral adipose tissue of KK-Ay mice, a genetic model of severe 
obesity and overt diabetes [14].  Liver and visceral adipose tissue have critical roles in the 
development of metabolic syndrome/type 2 diabetes [15,16].  In the liver, approximately 
10% of the genes are expressed circadianly, which may help maintain hepatic physiology 
[8,9].  Therefore, the circadian expression of various genes appears to be dampened in the 
livers of animals with metabolic syndrome/type 2 diabetes. 
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In general, the in vivo effects of metabolic abnormalities on gene expression are 
studied at only one scheduled time each day.  The effects of obese diabetes on the hepatic 
mRNA levels of several clock genes were observed only at their peak times [14].  
Therefore, differences in timing among experiments might cause diverse results, especially 
for genes expressed rhythmically.  To test this hypothesis, we investigated the effects of 
obese diabetes on the hepatic mRNA levels of various genes at different times of day, using 
microarray and real-time quantitative PCR analyses. 
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Materials and methods 
Mice 
Female KK/Ta and KK-Ay/Ta mice (n = 12 for each strain) were obtained from 
CLEA Japan (Tokyo, Japan) at 8 week of age and were maintained under specific 
pathogen-free conditions with controlled temperature and humidity and a 12-h light (07:00-
19:00 h)/12-h dark (19:00-07:00 h) cycle.  The mice were housed individually and were 
given a standard laboratory diet (CE-2; CLEA Japan) and water ad libitum.  After 2 weeks, 
animals were sacrificed to obtain blood and liver samples at the following zeitgeber times 
(ZT): 0, 6, 12, and 18, where ZT 0 is defined as lights on and ZT 12 as lights off.  All 
animal procedures were preformed in accordance with the Guidelines for Animal Research 
of Jichi Medical University, Japan. 
 
Measuring circulating glucose and insulin concentrations 
The blood glucose concentration was measured using a Glutest Ace R (Sanwa 
Kagaku Kenkyusyo, Nagoya, Japan).  The radioimmunoassay for serum insulin was 
performed using kits purchased from Linco Research (St. Charles, MO).  The intra- and 
interassay coefficients of variation were less than 10%. 
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 RNA isolation and microarray hybridization 
Total RNA was isolated from the liver samples using an RNeasy Mini kit (Qiagen, 
Valencia, CA).  The amount and quality of RNA were assessed using a NanoDrop ND-
1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE) and an Agilent 2100 
bioanalyzer (Agilent Technologies, Palo Alto, CA). 
We used the samples obtained at ZT 0 and 12 for the microarray analysis because 
CLOCK-BMAL1 transcriptional activity peaks in the early dark phase and reaches a 
minimum in the early light phase [17].  Fragmented, biotin-labeled amplified cDNA was 
prepared from 85 ng of total RNA using the Ovation Biotin System (NuGEN Technologies, 
San Carlos, CA), which is powered by Ribo-SPIA technology [18], according to the 
manufacturer’s instructions.  The cDNA (2.2 µg) was then hybridized to the GeneChip 
Mouse Expression Array 430A (Affymetrix, Santa Clara, CA), which contains 22,626 
probe sets primarily against well-annotated full-length genes, for 18 h at 45°C.  The chips 
were washed, and the signal was detected using standard Affymetrix reagents and protocols. 
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Analysis of the microarray data 
A scanned image was quantified using GeneChip operating software, version 1.2 
(Affymetrix) with the default parameters, and these data were analyzed using GeneSpring, 
version 7.2 (Agilent Technologies).  Initially, values less than 0.01 were set to 0.01.  After 
global normalization, each transcript was normalized to the median expression level across 
the samples obtained from KK mice at ZT 0.  Statistical comparisons between groups were 
made using one-way ANOVA, and the transcripts that showed a significantly (P < 0.05) 
greater than 2-fold or less than 0.5-fold change were subjected to GeneTree clustering. 
 
Quantitative reverse transcription-PCR 
Reverse transcription was performed with 1.2 µg of total RNA, random hexamer 
primers, and RevertAid M-MuLV reverse transcriptase (Fermentas, Hanover, MD).  The 
real-time quantitative PCR was performed with the ABI Prism 7700 sequence detection 
system (Applied Biosystems, Foster City, CA), as previously described [14,19].  All 
specific primer sets and TaqMan probes were obtained from Applied Biosystems, and their 
GenBank accession codes are shown in Table 1.  The data were analyzed using the 
comparative threshold cycle method [20].  To control the variation in the amount of DNA 
 8
available for PCR in the different samples, the gene expression of the target sequence was 




Differences in circulating glucose and insulin concentrations between KK and KK-
Ay mice were determined using the Mann-Whitney U test.  The rhythmicity of each gene 
was assessed using one-way ANOVA.  Differences in the mRNA levels at each time point 
between groups were evaluated using Student’s t-test.  The values are presented as the 
means ± SEM, and P < 0.05 was considered significant.  All calculations were performed 




Compared with KK mice, the strain with the Ay allele (KK-Ay) developed severe 
obesity (KK, 28.9 ± 0.5 g; KK-Ay, 43.5 ± 0.4 g; n = 12 in each strain; P < 0.01).  Moreover, 
in KK-Ay mice, marked hyperglycemia and hyperinsulinemia were observed throughout the 
day (Fig. 1).  Therefore, the KK-Ay mice had developed obese type 2 diabetes by the time 
of the study. 
The CLOCK-BMAL1 transcriptional activity peaks in the early dark phase and 
reaches a minimum in the early light phase [17]; therefore, microarray analyses were 
performed using the samples obtained from both strains at ZT 0 and 12 (n = 3 in each of the 
four groups).  We identified 343 transcripts whose levels differed significantly, by > 2-fold, 
among the groups (P < 0.05, one-way ANOVA) and subjected them to GeneTree clustering.  
As expected, the 12 samples were divided correctly into the four groups (Fig. 2).  Note that 
this analysis next grouped KK mice at ZT 12 and KK-Ay mice at ZT 12, rather than the 
same strains.  These results suggest that the mRNA expression of many genes exhibits daily 
rhythmicity not only in KK mice but also in KK-Ay mice.  Moreover, as a whole, the 
observed gene expression was influenced more by the time at which the observation was 
made than by obese diabetes. 
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Then, we investigated whether obese diabetes affects the circadian expression of 
various genes.  We selected those genes whose microarray expression levels differed by 
> 5-fold between ZT 0 and 12 in KK and KK-Ay mice and analyzed their expression levels 
at ZT 0, 6, 12, and 18, using real-time quantitative PCR.  As shown in Table 1, 19 of the 23 
selected genes showed significant rhythms of mRNA expression in both KK and KK-Ay 
mice, suggesting that our microarray analyses were effective for detecting circadianly 
expressed genes.  Four of the 19 genes (Dbp, Per3, Bmal1, and Npas2) are well-known 
clock and clock-controlled genes.  Significant rhythmicity in the expression of three other 
genes (Cdkn1a, Pstpip2, and Psmc6) was also observed in KK-Ay mice but not in KK mice.  
Therefore, these results confirm that the mRNA expression of various genes exhibits 24-h 
rhythmicity, even in obese diabetic mice.  As shown in Fig. 3, the phases of the daily 
expression rhythms of all 19 circadianly expressed genes detected in this study did not 
seem to differ between the strains.  However, obese diabetes significantly affected the 
mRNA levels of 13 rhythmically expressed genes at one or more observation time (Fig. 3A, 
B and C).  In particular, the peak levels of ten genes were significantly attenuated in KK-Ay 
mice compared with those in KK mice (Fig. 3A and B).  The differences between the 
strains were observed throughout the day in only two of the 13 genes (Por and Depdc6) 
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(Fig. 3A).  Therefore, obese diabetes dampened the rhythmic expression of various genes in 
the mouse liver, but these effects could be detected only at particular observation times in 




Previously, we showed that the rhythmic expression of the clock genes is attenuated 
in the liver of obese diabetic KK-Ay mice compared with control KK mice [14].  Given that 
the molecular clock consisting of clock genes is thought to regulate most circadian gene 
expression [1,2], obese diabetes should attenuate the rhythmic expression of most genes.  In 
this study, we found that the peak mRNA levels of more than half of the genes examined 
were reduced in the livers of KK-Ay mice, whereas the transcript levels of about one-third 
of the genes examined were hardly affected throughout the day.  Therefore, the influence of 
the molecular clock on rhythmic gene expression appears to vary among genes. 
In concordance with previous results [14], the peak transcript levels of the clock 
genes (Bmal1, Per3, and Dbp) in KK-Ay mice were significantly lower than those in KK 
mice (Fig. 3A and B).  By contrast, the mRNA level of neuronal PAS domain protein 2 
(NPAS2), another clock gene, did not differ between the strains.  NPAS2 is similar to 
CLOCK in amino acid sequence, and these transcription factors share BMAL1 as an 
obligate heterodimeric partner and bind to the same DNA recognition element [21].  The 
NPAS2-BMAL1 heterodimer, like CLOCK-BMAL1, is reported to play a role in 
maintaining circadian behaviors [22].  However, it remains unclear how NPAS2-BMAL1 
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affects the rhythmic gene expression in peripheral tissues.  Moreover, whether obese 
diabetes affects the NPAS2-BMAL1 activity, as well as the CLOCK-BMAL1 action, 
remains to be determined. 
Our results demonstrate that obese diabetes impairs the rhythmic expression of 
various genes, including Usp2, Upp2, Por, and Sphk2.  Ubiquitin-specific protease 2, a 
preproteasomal isopeptidase, has been reported to stabilize fatty acid synthase [23].  
Hepatic uridine phosphorylase inversely regulates the circulating uridine level, and its 
circadian rhythmicity might be involved in the humoral control of sleep by uridine [24].  
Cytochrome P450 oxidoreductase transfers electrons to all microsomal P450 enzymes, and 
its deficiency can affect steroidogenesis and drug metabolism [25].  Sphingosine kinase is a 
key enzyme modulating the cellular levels of sphingolipids, which are involved in 
regulating multiple cellular processes, including cell growth, apoptosis, and proliferation 
[26].  Therefore, obese diabetes probably dampens the circadian rhythmicity of various 
physiological functions.  Further studies are needed to clarify the pathophysiological roles 
of these effects in obese diabetes. 
It has been suggested that approximately 10% of the genes expressed in the liver 
and about 8% of the genes expressed in the heart exhibit circadian regulation [9].  As most 
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tissues, including the liver and heart, have an intracellular clock system [10,27], the 
expression of many genes in most organs is expected to exhibit rhythmicity.  Our results 
strongly suggest that gene expression analysis based on observations at only one time of 
day would tend to overlook the effect of obese diabetes if the gene were to show rhythmic 
regulation.  Therefore, the observed effects of obese diabetes, and possibly those of the 
other conditions, on many genes in various tissues might vary depending on the observation 
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Fig. 1.  Daily profiles of the serum glucose and insulin concentrations in KK (solid circles) 
and KK-Ay mice (open circles).  Data are the means ± SEM of three mice at each time 
point.  *, P < 0.05 vs. KK mice. 
 
Fig. 2.  GeneTree clustering analysis of gene expression profiles in the livers of KK and 
KK-Ay mice obtained at ZT 0 and 12 (n = 3 for each time point in both mice).  The 
transcripts with significantly different levels (P < 0.05, one-way ANOVA), i.e., > 2-fold, 
among the four groups were used for the clustering.  The increased expression is shown in 
red; decreased expression is shown in blue. 
 
Fig. 3.  Daily mRNA expression profiles of the circadianly expressed genes in the livers of 
KK (solid circles) and KK-Ay mice (open circles).  Liver samples were obtained from both 
mice at ZT 0, 6, 12, and 18.  Transcript levels were determined using real-time quantitative 
reverse transcription-PCR.  Data are the means ± SEM of three mice at each time point and 
are expressed as values relative to the highest values in KK mice for each gene.  
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